For decades, hyperbaric oxygen therapy (HBOT) has meant high-pressure chambers running at 2.0 to 3.0 atmospheres absolute (ATA). Mild chambers at 1.3 to 1.5 ATA are now widely available, and the question people ask before choosing one is simple: does the lower pressure still deliver results?

Published research says yes for a growing number of goals. Mild HBOT at 1.3 to 1.5 ATA has produced measurable results in studies on sleep quality, recovery in elite athletes, children’s development and skin health, while the landmark study on cellular ageing used 2.0 ATA. Clinical guidelines place the minimum pressure for an effect at 1.4 ATA, and research indicates that benefits for the brain are often optimised between 1.3 and 1.75 ATA. The lower pressure also brings better accessibility, safety and comfort, which makes regular, long-term use realistic.

The sections below compare the two pressure ranges, then go through the evidence goal by goal.

What is the difference between mild HBOT and high-pressure HBOT?

Traditional HBOT runs at 2.0 to 3.0 ATA with 100 % oxygen; mild HBOT runs at 1.3 to 1.5 ATA. The gap looks small on paper, but it changes accessibility and how easy it is to keep up a protocol, while research increasingly shows that lower pressures reach results across several domains.

Mild HBOT High-pressure HBOT
Pressure 1.3 to 1.5 ATA 2.0 to 3.0 ATA
Oxygen concentration in the studies cited 24 % to 100 % 100 %
Typical use Regular sessions, long protocols, home and wellness settings Acute medical intervention, serious injuries, intensive recovery periods
Main advantages Accessibility, safety, comfort, long-term use Maximum pressure

What does the research show, goal by goal?

Six areas have published results, at pressures from 1.25 to 2.0 ATA.

Cellular ageing: telomeres and senescent cells

A landmark study in the peer-reviewed journal Aging showed that HBOT can increase telomere length by over 20 % and reduce senescent cells in healthy ageing adults. The protocol used 60 daily sessions at 2.0 ATA. Telomere length in immune cells increased by 25 to 37 %, and senescent T helper cells decreased by 37 %, changes that lifestyle interventions typically reach at only 2 to 5 %. It is the first human study to show cellular-level age reversal through a non-pharmacological intervention. Research also indicates that benefits for the brain are often optimised between 1.3 and 1.75 ATA, as the brain is particularly sensitive to oxygen and pressure.

The pressure threshold set by clinical guidelines

Clinical guidelines from the Underwater and Hyperbaric Medical Society indicate that a pressure of 1.4 ATA is required for an effect in wound healing, one of HBOT’s most established indications. 1.5 ATA meets that threshold. Protocols between 1.4 and 2.5 ATA have all shown efficacy depending on session duration and frequency: consistency and adequate tissue oxygenation matter more than maximum pressure.

Sleep quality

A randomised trial on adults with chronic insomnia at high altitude found that a 10-day HBOT course improved both the Pittsburgh Sleep Quality Index (PSQI) and the Insomnia Severity Index (ISI). In military personnel with mild traumatic brain injury, HBOT at 1.5 ATA improved five of eight PSQI sleep measures at 13 weeks and two of eight at six months. The mechanisms appear multifactorial: better cerebral oxygen metabolism, reduced inflammation and support for the brain’s glymphatic system, the waste-clearance process that runs during deep sleep. In children with cerebral palsy, total sleep items improved after 10 and 20 sessions, with the protocol found safe and effective.

Children with autism

A multicentre, double-blind study using 1.3 ATA with 24 % oxygen for 40 sessions showed improvements in physician CGI scores for overall functioning, receptive language, social interaction, eye contact and sensory and cognitive awareness, compared with slightly pressurised room air. Studies at pressures up to 1.5 ATA with 100 % oxygen have been reported as safe and well tolerated, with lower inflammation markers measured by CRP levels.

Athletic recovery

Olympic athletes at the Nagano Winter Olympics received HBOT at 1.3 ATA for 30 to 40 minutes, with a maximum of six sessions, and all reported faster recovery. The lower pressure was sufficient to accelerate lactate and ammonia clearance. A study on Chinese secondary national-level athletes using mild HBOT at 1.25 ATA with 26 to 28 % oxygen showed reduced subjective fatigue and better recovery markers than controls. Mild protocols at 1.3 to 1.5 ATA appear effective for recovery between training sessions, while higher pressures may be reserved for serious injuries or intensive recovery periods.

Skin health and ageing

A prospective clinical trial of 60 daily HBOT sessions in older adults increased collagen density, elastic fibre length and the number of blood vessels, while decreasing senescent cells and papillary dermis thickness. Tissue biopsies confirmed the changes at the cellular level: collagen fibre density increased with a large effect size, and elastic fibre length increased by nearly three times the baseline variation. The mechanism is well understood: oxygen is essential for collagen synthesis, and higher tissue oxygenation stimulates fibroblasts, the cells that produce structural proteins. Regular sessions increase skin elasticity and collagen production, which reduces wrinkles and fine lines and improves skin texture. Many dermatology clinics now add mild HBOT protocols at 1.3 to 1.5 ATA alongside topical care, a from-within approach to skin rejuvenation.

Which pressure for which goal?

The studies above point to one rule: match pressure, oxygen concentration and session frequency to the goal, rather than defaulting to the highest pressure available.

Goal Pressure in the research Protocol in the study
Cellular ageing 2.0 ATA 60 daily sessions
Sleep quality 1.5 ATA (mild traumatic brain injury study) 10-day course in adults; 10 and 20 sessions in children
Children with autism 1.3 ATA, 24 % oxygen 40 sessions
Athletic recovery 1.25 to 1.3 ATA 30 to 40 minutes, up to 6 sessions
Skin health 1.3 to 1.5 ATA in dermatology clinics 60 daily sessions in the trial
Wound healing threshold 1.4 ATA minimum (guidelines) 1.4 to 2.5 ATA depending on duration and frequency

Mild HBOT makes this approach more accessible, affordable and practical for long-term use. As research keeps validating lower-pressure protocols, HBOT moves from an acute medical intervention to a versatile tool for optimisation, prevention and regeneration.

Key takeaways

References

  1. Telomere Lengthening Study: Hachmo Y, Hadanny A, Abu Hamed R, et al. Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. Aging. 2020;12(22):22445-22456. https://pubmed.ncbi.nlm.nih.gov/33206062/
  2. Cell-Level Aging Reversal: ScienceDaily. Hyperbaric oxygen treatment: Clinical trial reverses two biological processes associated with aging in human cells. November 2020. https://www.sciencedaily.com/releases/2020/11/201120150728.htm
  3. UHMS Clinical Guidelines: Underwater and Hyperbaric Medical Society guidelines indicate pressures of at least 1.4 ATA are required for an effect in wound healing.
  4. Multicenter Double-Blind Study: Rossignol DA, et al. Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial. BMC Pediatrics. 2009;9:21. https://bmcpediatr.biomedcentral.com/articles/10.1186/1471-2431-9-21
  5. Mitochondrial Biogenesis Study: Hadanny A, Hachmo Y, Rozali D, et al. Effects of Hyperbaric Oxygen Therapy on Mitochondrial Respiration and Physical Performance in Middle-Aged Athletes: A Blinded, Randomized Controlled Trial. Sports Medicine Open. 2022;8(1):22. https://sportsmedicine-open.springeropen.com/articles/10.1186/s40798-021-00403-w
  6. PubMed Reference: Effects of Hyperbaric Oxygen Therapy on Mitochondrial Respiration and Physical Performance in Middle-Aged Athletes. https://pubmed.ncbi.nlm.nih.gov/35133516/
  7. PubMed Skin Study: The effect of hyperbaric oxygen therapy on the pathophysiology of skin aging. https://pmc.ncbi.nlm.nih.gov/articles/PMC8660605/
  8. HBOT for mTBI Post Concussion: Harch PG, et al. Hyperbaric oxygen therapy for mild traumatic brain injury persistent postconcussion syndrome: a randomized controlled trial. Medical Gas Research. 2020. https://hbot.com/hbot-for-mtbi-post-concussion-syndrom-randomized-controlled-trial/

More studies by goal are available in the Oxygenome research library.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any hyperbaric oxygen protocol.